Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
|Articles|March 1, 2007
- Applied Clinical Trials-03-01-2007
- Volume 0
- Issue 0
eShowcase: Clin'Form
Digital writing solution speeds up data harvest while ensuring traceability and capture ease
Advertisement
Digital writing solution speeds up data harvest while ensuring traceability and capture ease
Kayentis (Paris, France) is out with a digital pen and paper technology product, called Clin'Form, designed to streamline handwritten entry of clinical trial data into an electronic CRF through a collaborative, Web-based portal. The product is based on the Forms Automation System architecture using the Anoto Digital Pen & Paper technology.
Clin'Form enables a complete audit trail with full information traceability for data captured with digital pens. Also, tracking key users, including trial investigators, CRAs, and data managers, is possible, as well as study progress reports in real time on such measures as center openings, patient inclusion rates, and CRF completion follow-up. Once collected, Clin'Form facilitates the push of data to clinical data management systems in CDISC-compatible format, adding to its versatility.
Kayentis, (609) 627-5300,
Articles in this issue
over 19 years ago
Europe's Pediatric Rules in Force—At Lastover 19 years ago
Pressure Mounts to Streamline Trialsover 19 years ago
Is Something Better than Nothing?over 19 years ago
Promoting Clinical Trials in Japanover 19 years ago
eShowcase: Business Services Dashboardover 19 years ago
The Critical Path Initiative Meets Medical Devicesover 19 years ago
Taking Computers into the Next Virtual Realmover 19 years ago
eShowcase: Liquent InSight v. 3.5over 19 years ago
Blinded by Science with Adaptive Designsover 19 years ago
Increase Your Company's Value with EDMAdvertisement
Related to this article
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
AstraZeneca and Oracle Outline AI Collaboration for Clinical Trial Recruitment and Safety Monitoring
What sponsors and sites should know about the AstraZeneca-Oracle AI collaboration on trial recruitment, safety monitoring and data governance.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, identifies three recurring failure modes in AI governance frameworks—and explains why responsible AI must be an ongoing operating discipline, not a one-time approval gate.
CRIO’s chief innovation officer, Mike Wenger touches on the two ways sites get AI adoption wrong.
CRIO’s Mike Wenger, speaker at this year's SCRS summit, maps how sites are actually deploying AI post-pilot stage.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the real advantage of faster data isn’t speed—it’s shortening the distance between signals, human judgment, and the next best action.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Syneos Health, Optum Partner on Adaptive Clinical Development Model
2
Where AI Governance in Clinical Development Falls Short
3
AstraZeneca and Oracle Outline AI Collaboration for Clinical Trial Recruitment and Safety Monitoring
4
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
5